Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory Drugs
NCT06160167
·
clinicaltrials.gov ↗
COMPLETED
Status
4204
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
IMiD treatment
DRUG:
No IMiD treatment
DRUG:
Systemic therapy
Sponsor
Bristol-Myers Squibb